NEUP Stock Analysis: Buy, Sell, or Hold?
NEUP - Neuphoria Therapeutics Inc. Common Stock
$3.93
0.05 (1.29%)
▲
5d:
+2.08%
30d:
+16.27%
90d:
-24.71%
BUY
HIGH Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Get Alerted When NEUP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NEUP shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: NEUP shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: NEUP is currently trading at $3.93, which is considered slightly high relative to its 30-day fair value range of $3.37 to $4.03.
Technical Outlook: Technically, NEUP is in a downtrend. Immediate support is located at $3.28, while resistance sits at $4.20.
Market Sentiment: NEUP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+78.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEUP is in a downtrend. Immediate support is located at $3.28, while resistance sits at $4.20.
Market Sentiment: NEUP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+78.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.37 -
$4.03
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.1% below Wall St target ($7.00)
Trading Range Analysis
30-Day Trading Range
$3.37 -
$4.03
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.28
Resistance Level
$4.20
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$7.00
(+78.1%)
Share & Embed Analysis
Last updated: August 04, 2026 7:40 AM ET
Data refreshes hourly during market hours. Next update: 8:40 AM
Data refreshes hourly during market hours. Next update: 8:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEUP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
